The American Nurses Association (ANA) Dept. of Nursing Practice and Policy shares the following information received from the National Vaccine Program Office in the US Dept. of Health and Human Services (HHS):
After more than 104 million doses of H1N1 vaccine have been given, safety data show no “signals” linking serious adverse events, such as Guilliain-Barré Syndrome, to the vaccine. The report also concludes that the number and type of reports of post-vaccine events are similar to those from seasonal influenza vaccine, and no serious side effects were identified in pregnant women after vaccination. This is according to a report released by the H1N1 Vaccine Safety Risk Assessment Working Group, which was established by the National Vaccine Advisory Committee to conduct independent, rapid reviews of available safety monitoring data for the 2009 H1N1 influenza vaccines.
The report confirms the H1N1 vaccine is safe, even for infants and pregnant women. The subcommittee will continue to monitor safety data on a monthly basis. This is the ninth report released by the group, and none of which have identified any major safety problems.
Read the Report, including all the conclusions from all data collection systems.